ProShares Ultra Nasdaq Biotechnology ETF Stock Price, News & Analysis (NASDAQ:BIB)

$61.54 0.77 (1.27 %)
(As of 01/21/2018 04:00 PM ET)
Previous Close$61.54
Today's Range$60.84 - $61.70
52-Week Range$40.22 - $64.51
Volume125,071 shs
Average Volume203,605 shs
Market Capitalization$449.70 million
P/E RatioN/A
Dividend YieldN/A
Beta2.75

About ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Receive BIB News and Ratings via Email

Sign-up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Investment Trusts
Sub-IndustryN/A
SectorFinancials
SymbolNASDAQ:BIB
CUSIPN/A
Phone+1-240-4976400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares7,400,000

ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) Frequently Asked Questions

What is ProShares Ultra Nasdaq Biotechnology ETF's stock symbol?

ProShares Ultra Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "BIB."

Who are some of ProShares Ultra Nasdaq Biotechnology ETF's key competitors?

Who owns ProShares Ultra Nasdaq Biotechnology ETF stock?

ProShares Ultra Nasdaq Biotechnology ETF's stock is owned by a number of of retail and institutional investors. Top institutional investors include Private Capital Advisors Inc. (0.52%), Koshinski Asset Management Inc. (0.07%), Creative Planning (0.06%) and Simplex Trading LLC (0.03%). View Institutional Ownership Trends for ProShares Ultra Nasdaq Biotechnology ETF.

Who sold ProShares Ultra Nasdaq Biotechnology ETF stock? Who is selling ProShares Ultra Nasdaq Biotechnology ETF stock?

ProShares Ultra Nasdaq Biotechnology ETF's stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, Koshinski Asset Management Inc. and Creative Planning. View Insider Buying and Selling for ProShares Ultra Nasdaq Biotechnology ETF.

Who bought ProShares Ultra Nasdaq Biotechnology ETF stock? Who is buying ProShares Ultra Nasdaq Biotechnology ETF stock?

ProShares Ultra Nasdaq Biotechnology ETF's stock was purchased by a variety of institutional investors in the last quarter, including Private Capital Advisors Inc.. View Insider Buying and Selling for ProShares Ultra Nasdaq Biotechnology ETF.

How do I buy ProShares Ultra Nasdaq Biotechnology ETF stock?

Shares of ProShares Ultra Nasdaq Biotechnology ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProShares Ultra Nasdaq Biotechnology ETF's stock price today?

One share of ProShares Ultra Nasdaq Biotechnology ETF stock can currently be purchased for approximately $61.54.

How big of a company is ProShares Ultra Nasdaq Biotechnology ETF?

ProShares Ultra Nasdaq Biotechnology ETF has a market capitalization of $449.70 million.

How can I contact ProShares Ultra Nasdaq Biotechnology ETF?

ProShares Ultra Nasdaq Biotechnology ETF's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The exchange traded fund can be reached via phone at +1-240-4976400.


MarketBeat Community Rating for ProShares Ultra Nasdaq Biotechnology ETF (BIB)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about ProShares Ultra Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Show:

Dividends

Dividend History for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)


No dividend announcements for this company have been tracked by MarketBeat.com

Headlines

ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ BIB) News Headlines

Source:
DateHeadline
BIB Crowded With SellersBIB Crowded With Sellers
www.thestreet.com - October 24 at 11:45 PM
Biotech, Pharma ETFs Leave Pricing Drama BehindBiotech, Pharma ETFs Leave Pricing Drama Behind
finance.yahoo.com - September 15 at 4:55 PM
Biotech ETF Investing is Hot, Can Get HotterBiotech ETF Investing is Hot, Can Get Hotter
finance.yahoo.com - September 8 at 4:53 PM
Why $475,000 isn't actually that expensive for Novartis's new drugWhy $475,000 isn't actually that expensive for Novartis's new drug
finance.yahoo.com - September 2 at 4:11 PM
Biotech ETF Investing is Starting to Look Good – Here’s WhyBiotech ETF Investing is Starting to Look Good – Here’s Why
finance.yahoo.com - August 30 at 5:51 PM
BIBs Underlying Holdings Could Mean 18% Gain PotentialBIB's Underlying Holdings Could Mean 18% Gain Potential
www.thestreet.com - June 5 at 12:46 PM
BIB Makes Bullish Cross Above Critical Moving AverageBIB Makes Bullish Cross Above Critical Moving Average
www.thestreet.com - June 1 at 4:21 PM
BIB, BIIB, REGN, ILMN: Large Outflows Detected at ETFBIB, BIIB, REGN, ILMN: Large Outflows Detected at ETF
www.nasdaq.com - February 13 at 4:25 PM
Biotech Suffered Big Outflows Again Last Week, Pushing Back A Recovery - Barrons (blog)Biotech Suffered Big Outflows Again Last Week, Pushing Back A Recovery - Barron's (blog)
blogs.barrons.com - January 30 at 3:45 PM
Biotech Suffered Big Outflows Again Last Week, Pushing Back A RecoveryBiotech Suffered Big Outflows Again Last Week, Pushing Back A Recovery
blogs.barrons.com - January 30 at 3:45 PM
Republicans advancing changes to Obamacare - Seeking AlphaRepublicans advancing changes to Obamacare - Seeking Alpha
seekingalpha.com - January 26 at 4:35 PM
Trump Foreshadows a Bleak Outlook for Biotech - InvestopediaTrump Foreshadows a Bleak Outlook for Biotech - Investopedia
www.investopedia.com - January 18 at 3:19 PM
Trump Foreshadows a Bleak Outlook for BiotechTrump Foreshadows a Bleak Outlook for Biotech
www.investopedia.com - January 18 at 3:19 PM
The Most-Shorted Stocks In Health Care In 2016 Were... - Barrons (blog)The Most-Shorted Stocks In Health Care In 2016 Were... - Barron's (blog)
blogs.barrons.com - January 7 at 4:27 PM
The Most-Shorted Stocks In Health Care In 2016 Were…The Most-Shorted Stocks In Health Care In 2016 Were…
blogs.barrons.com - January 6 at 4:14 PM
Will Biotech Find Its Footing In 2017? - Barrons (blog)Will Biotech Find Its Footing In 2017? - Barron's (blog)
blogs.barrons.com - January 6 at 2:22 AM
Will Biotech Find Its Footing In 2017?Will Biotech Find Its Footing In 2017?
blogs.barrons.com - January 4 at 4:01 PM
Biotech ETFs: A Short-Lived Boon From Biogen - Barrons (blog)Biotech ETFs: A Short-Lived Boon From Biogen - Barron's (blog)
blogs.barrons.com - December 9 at 8:59 PM
Biotech ETFs: A Short-Lived Boon From BiogenBiotech ETFs: A Short-Lived Boon From Biogen
blogs.barrons.com - December 9 at 8:59 PM
ProShares UltraPro Nasdaq Biotechnology (UBIO) Enters Oversold TerritoryProShares UltraPro Nasdaq Biotechnology (UBIO) Enters Oversold Territory
www.thestreet.com - November 2 at 3:30 PM
Avoid Biotech After BrexitAvoid Biotech After Brexit
seekingalpha.com - June 28 at 4:02 PM
Biotech Strategy Following Brexit: Run, Dont WalkBiotech Strategy Following Brexit: Run, Don't Walk
seekingalpha.com - June 27 at 3:28 PM
Biotechnology: Ready To Move Higher - Much HigherBiotechnology: Ready To Move Higher - Much Higher
seekingalpha.com - June 3 at 12:21 PM
BIB vs. LABU: Comparing Leveraged Biotech ETFsBIB vs. LABU: Comparing Leveraged Biotech ETFs
www.investopedia.com - May 4 at 9:21 PM
The Five Best Stocks To Short In May - ForbesThe Five Best Stocks To Short In May - Forbes
www.forbes.com - May 3 at 2:58 PM
Gravity Kills: 40 ETFs Own Big Slugs of Apple - Barrons (blog)Gravity Kills: 40 ETFs Own Big Slugs of Apple - Barron's (blog)
blogs.barrons.com - April 28 at 2:55 PM
ETFs: Price-Change Prospects For SA Readers 20 Most Popular Funds - Seeking AlphaETFs: Price-Change Prospects For SA Readers' 20 Most Popular Funds - Seeking Alpha
seekingalpha.com - April 6 at 2:55 PM
Near Price-Change Prospects - Best And Worst - For SA Readers 20 Biggest-Interest ETFs - Seeking AlphaNear Price-Change Prospects - Best And Worst - For SA Readers' 20 Biggest-Interest ETFs - Seeking Alpha
seekingalpha.com - April 5 at 2:40 PM
DUST, BIS: Big ETF OutflowsDUST, BIS: Big ETF Outflows
www.forbes.com - April 4 at 2:35 PM
Are These ETFs Making You An April Fool? - NasdaqAre These ETFs Making You An April Fool? - Nasdaq
www.nasdaq.com - April 2 at 2:44 PM
The Implied Analyst 12-Month Target For BIBThe Implied Analyst 12-Month Target For BIB
www.thestreet.com - March 22 at 2:31 PM
Better To Short Biotech ETF Or To Invest In Inverse Counterpart?Better To Short Biotech ETF Or To Invest In Inverse Counterpart?
www.nasdaq.com - March 16 at 2:44 PM
Is It A Bull Or Bubble? - Seeking AlphaIs It A Bull Or Bubble? - Seeking Alpha
seekingalpha.com - March 11 at 1:44 PM
Is The Biotech Bear Market Over?Is The Biotech Bear Market Over?
www.forbes.com - February 29 at 9:43 PM

SEC Filings

ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ BIB) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.